• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Agios Pharmaceuticals Inc

+ Add to Watchlist

AGIO:US

45.4400 USD 0.9600 2.16%

As of 20:10:00 ET on 08/27/2014.

Snapshot for Agios Pharmaceuticals Inc (AGIO)

Open: 44.7500 Day's Range: 44.3901 - 46.2200 Volume: 249,398
Previous Close: 44.4800 52wk Range: 15.7700 - 50.3700 1-Yr Rtn: +96.71%

Stock Chart for AGIO

No chart data available.
  • AGIO:US 45.4370
  • 1D
  • 1M
  • 1Y
44.4800
Interactive AGIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8000
Est. EPS (USD) (12/2014) -1.8660
Est. PEG Ratio -
Market Cap (M USD) 1,565.77
Shares Outstanding (M) 34.46
30 Day Average Volume 298,716
Price/Book (mrq) 7.7999
Price/Sale (ttm) 44.9774
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AGIO

Agios Pharmaceuticals, Inc. discovers and develops therapeutics in the field of cancer metabolism. The Company develops drugs focusing on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.

David P SchenkeinChief Executive OfficerJ Duncan HiggonsChief Operating Officer
Craig MuirCTO/CIOChris BowdenChief Medical Officer
More Company Profile & Key Executives for AGIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil